Cargando…

Regulation of Epithelial Cell Tight Junctions by Protease-Activated Receptor 2

A layer of epithelial cells prevents the invasion of bacteria and the entry of foreign substances into the underlying tissue. The disruption of epithelial tight junctions initiates and exacerbates inflammation. However, the precise mechanism underlying the disruption of the epithelial tight junction...

Descripción completa

Detalles Bibliográficos
Autores principales: ENJOJI, Shuhei, OHAMA, Takashi, SATO, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Veterinary Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197149/
https://www.ncbi.nlm.nih.gov/pubmed/24881651
http://dx.doi.org/10.1292/jvms.14-0191
_version_ 1782339568545038336
author ENJOJI, Shuhei
OHAMA, Takashi
SATO, Koichi
author_facet ENJOJI, Shuhei
OHAMA, Takashi
SATO, Koichi
author_sort ENJOJI, Shuhei
collection PubMed
description A layer of epithelial cells prevents the invasion of bacteria and the entry of foreign substances into the underlying tissue. The disruption of epithelial tight junctions initiates and exacerbates inflammation. However, the precise mechanism underlying the disruption of the epithelial tight junction remains unclear. The activation of protease-activated receptor 2 (PAR2) by serine proteases produced by some bacteria and mast cells contributes to inflammation in many tissues. In the present study, we tested the hypothesis that PAR2 activation affects the structure and function of tight junctions in Madin-Darby canine kidney (MDCK) cells. Although the application of a PAR2-activating peptide, PAR2-AP, from the apical side of MDCK cells failed to modify the transepithelial resistance (TER), its application from the basal side markedly suppressed the TER. In 3-dimensional cultures of MDCK cells expressing the mCherry-tagged PAR2, a lateral localization of PAR2 was observed. The application of PAR2-AP from the basal side changed the localization of the tight junctional protein, zonula occludin-1. Furthermore, PAR2-AP induced the phosphorylation of p38 MAP kinase. A p38 MAP kinase inhibitor, SB202190, inhibited PAR2-AP-induced changes in TER. Our results suggest that the activation of PAR2 leads to the disruption of tight junctions and increases the barrier permeability through the activation of p38 MAPK, which may cause the initiation and exacerbation of inflammation.
format Online
Article
Text
id pubmed-4197149
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher The Japanese Society of Veterinary Science
record_format MEDLINE/PubMed
spelling pubmed-41971492014-10-17 Regulation of Epithelial Cell Tight Junctions by Protease-Activated Receptor 2 ENJOJI, Shuhei OHAMA, Takashi SATO, Koichi J Vet Med Sci Pharmacology A layer of epithelial cells prevents the invasion of bacteria and the entry of foreign substances into the underlying tissue. The disruption of epithelial tight junctions initiates and exacerbates inflammation. However, the precise mechanism underlying the disruption of the epithelial tight junction remains unclear. The activation of protease-activated receptor 2 (PAR2) by serine proteases produced by some bacteria and mast cells contributes to inflammation in many tissues. In the present study, we tested the hypothesis that PAR2 activation affects the structure and function of tight junctions in Madin-Darby canine kidney (MDCK) cells. Although the application of a PAR2-activating peptide, PAR2-AP, from the apical side of MDCK cells failed to modify the transepithelial resistance (TER), its application from the basal side markedly suppressed the TER. In 3-dimensional cultures of MDCK cells expressing the mCherry-tagged PAR2, a lateral localization of PAR2 was observed. The application of PAR2-AP from the basal side changed the localization of the tight junctional protein, zonula occludin-1. Furthermore, PAR2-AP induced the phosphorylation of p38 MAP kinase. A p38 MAP kinase inhibitor, SB202190, inhibited PAR2-AP-induced changes in TER. Our results suggest that the activation of PAR2 leads to the disruption of tight junctions and increases the barrier permeability through the activation of p38 MAPK, which may cause the initiation and exacerbation of inflammation. The Japanese Society of Veterinary Science 2014-05-30 2014-09 /pmc/articles/PMC4197149/ /pubmed/24881651 http://dx.doi.org/10.1292/jvms.14-0191 Text en ©2014 The Japanese Society of Veterinary Science http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License.
spellingShingle Pharmacology
ENJOJI, Shuhei
OHAMA, Takashi
SATO, Koichi
Regulation of Epithelial Cell Tight Junctions by Protease-Activated Receptor 2
title Regulation of Epithelial Cell Tight Junctions by Protease-Activated Receptor 2
title_full Regulation of Epithelial Cell Tight Junctions by Protease-Activated Receptor 2
title_fullStr Regulation of Epithelial Cell Tight Junctions by Protease-Activated Receptor 2
title_full_unstemmed Regulation of Epithelial Cell Tight Junctions by Protease-Activated Receptor 2
title_short Regulation of Epithelial Cell Tight Junctions by Protease-Activated Receptor 2
title_sort regulation of epithelial cell tight junctions by protease-activated receptor 2
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197149/
https://www.ncbi.nlm.nih.gov/pubmed/24881651
http://dx.doi.org/10.1292/jvms.14-0191
work_keys_str_mv AT enjojishuhei regulationofepithelialcelltightjunctionsbyproteaseactivatedreceptor2
AT ohamatakashi regulationofepithelialcelltightjunctionsbyproteaseactivatedreceptor2
AT satokoichi regulationofepithelialcelltightjunctionsbyproteaseactivatedreceptor2